Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...
Article cites potential to save money on end-of-life care, medical imaging and new drug prices In a review article published Feb. 14 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue ...
HealthDay Reporter Latest Cancer News Pain One Year After Breast Cancer Surgery Experimental Treatment for Rare Soft-Tissue Cancer Cancer Patients Vulnerable to Flu Complications Surgery With Radiation Best for Tongue Cancer Only High-Risk ...
Tags: Health, Medicine, Childhood Cancer
Four out of five doctors who treat cancer were unable to prescribe their medication of choice at least once during a six-month period because of a drug shortage, according to a new survey. The survey also found that more than 75 percent ...
If you've ever had trouble affording your medications and wanted to call your doctor on it, here's some encouraging news: Doctors aren't pleased about the prices either. Denouncing "profiteering" by pharmaceutical companies, more than 100 ...
MIT researchers are using nanotechnology to help doctors detect cancer in their patients sooner, increasing their odds of beating the disease. To diagnose cancer, doctors look for specific proteins secreted by cancer cells. The problem ...
Tags: MIT, nanotechnology, detect cancer, specific proteins
Phenogen Sciences, a subsidiary of Genetic Technologies, has unveiled a non-invasive genetic risk assessment test for women with estrogen-receptor positive breast cancer. The BREVAGen uses patients oral-swab samples to calculate patient's ...
Tags: non-invasive genetic risk assessment test, cancer test